Gamal Mohamed Taha Abouelmagd
1 clinical trials · Sponsor
◉ Watch Gamal Mohamed Taha Abouelmagd
| Record | Firm | Date |
|---|---|---|
| Lidocaine Versus Duloxetine for the Prevention of Taxane-Induced Peripheral Neuropathy In Breast Cancer Patients (NCT04732455) | Gamal Mohamed Taha Abouelmagd | 2021-01-15 |
Track Gamal Mohamed Taha Abouelmagd automatically
Every clearance here is in the API, with alerts when new ones post.